Dr Vince Polito, a clinical psychologist and Senior Research Fellow at Macquarie University’s School of Psychological Sciences, is leading a clinical trial to test the effectiveness of regular, tiny doses of psychedelics on moderate depression. ...
International scientists have developed an assessment proposal aimed at clinicians and researchers to establish an individualised treatment protocol for long COVID patients. It is estimated that one out of 10 people who have suffered from ...
Brain cancer is a disease that largely affects children, and is a complex condition to get around. Cure Brain Cancer Foundation’s newly-installed CEO Lance Kawaguchi discusses his plans and key causes for the foundation in ...
Cure Brain Cancer Foundation (CBCF), the leading charity for brain cancer research, awareness and advocacy in the region, has announced a partnership with the Global Coalition for Adaptive Research (GCAR) to bring a revolutionary, first ...
In the lead up to World AIDS Day, NSW Health is encouraging people across the state at risk of HIV to get tested. As NSW opens up, it is a good time for the community ...
From 1 December 2021, Australians with acute myeloid leukaemia (AML) will have access to a new treatment option on the Pharmaceutical Benefits Scheme (PBS). The Morrison Government is expanding the list of Venclexta (venetoclax) for ...
The diagnosis and treatment of children with Fetal Alcohol Spectrum Disorder (FASD) is set to be strengthened with the announcement of $3.68 million in funding from the Federal Government’s Drug and Alcohol Program awarded to ...
A new targeted treatment for mutant proteins which can cause the deadliest of cancers in humans has been uncovered by scientists at the University of Leeds. The mutated form of the RAS protein has been ...
Researchers at the Francis Crick Institute and the University of Dundee have screened thousands of drug and chemical molecules and identified a range of potential antivirals that could be developed into new treatments for COVID-19 ...
Its inventor, UQ Diamantina Institute’s Dr. Fiona Simpson, said it could be used to show how long antibodies stayed active in patients, or when antibodies were taken into the tumour where they’re destroyed. The ...
Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector
We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
